The course of COVID-19 infection and prolonged sneezing and nasal congestion in a patient using ixekizumab
Dermatol Ther
.
2021 Mar;34(2):e14894.
doi: 10.1111/dth.14894.
Epub 2021 Feb 23.
Authors
Semih Güder
1
,
Hüsna Güder
2
Affiliations
1
Department of Dermatology, Medical Faculty, Bezmialem Vakif University, Istanbul, Turkey.
2
Department of Dermatology, Medical Faculty, Maltepe University, Istanbul, Turkey.
PMID:
33599042
PMCID:
PMC7995103
DOI:
10.1111/dth.14894
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized
COVID-19*
Humans
SARS-CoV-2
Sneezing*
Substances
Antibodies, Monoclonal, Humanized
ixekizumab